Understanding Beta Cell Changes in Type 2 Diabetes
Beta cell Notch activity in Type 2 Diabetes
This project looks into how certain cells in the pancreas, called beta cells, change in people with Type 2 Diabetes to find new ways to help them work better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11055470 on NIH RePORTER |
What this research studies
Our bodies rely on beta cells in the pancreas to make enough insulin and keep blood sugar levels balanced. In Type 2 Diabetes, these beta cells don't work as well, leading to high blood sugar. This project explores a specific communication pathway, called Notch signaling, within beta cells to understand why they stop adapting effectively. We believe that by understanding and potentially adjusting this pathway, we could help beta cells regain their ability to produce insulin properly. The goal is to discover new targets for future treatments that could improve beta cell function for those living with Type 2 Diabetes.
Who could benefit from this research
Good fit: This foundational research is for anyone interested in the underlying causes of Type 2 Diabetes and future treatment options.
Not a fit: Patients seeking immediate new treatments or direct clinical trial participation would not directly benefit from this early-stage laboratory research.
Why it matters
Potential benefit: If successful, this work could identify new targets for medications that restore healthy beta cell function and improve blood sugar control for people with Type 2 Diabetes.
How similar studies have performed: While Notch signaling is known to be important in cell development, its specific role in mature beta cells and Type 2 Diabetes is a newer area of exploration, making this approach relatively novel.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Pajvani, Utpal — Columbia University Health Sciences
- Study coordinator: Pajvani, Utpal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.